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1470 Abstracts May 2014time to healing of the reference leg, health-related quality of life, resource
use, treatment change, adverse events, and ulcer recurrence. Health-related
quality of life and resource use were measured at baseline and every 3
months thereafter by participant self-completion of the SF-12 and
EQ-5D. Adverse events were classiﬁed as serious (death, life-threatening,
or limb-threatening) or non-serious. After the reference leg ulcer healed
nurses assessed ulcer recurrence on a monthly basis. There were 457 partic-
ipants in the two treatment groups: 230 in the two-layer group and 227 in
the four-layer bandage group. Of these, 230 in the hosiery and 223 in the
bandage group contributed data for analysis. Median time to ulcer healing
was 99 days (95% CI, 84-126) in the hosiery group and 98 days (95% CI,
85-112) in the bandage group. The proportion of ulcer healing was the
same in the two groups (70.9% hosiery and 70.4% bandage). There was
no evidence of a difference in the mental component summary score by
treatment over 12 months. Patients allocated to hosiery had a higher phys-
ical component summary score than those assigned to four-layer bandages,
suggesting better physical health in the hosiery group. This was after adjust-
ment for ulcer area, ulcer duration, participant mobility, center and time.
One hundred ﬁfty of the 454 (33%) participants changed to a non-trial
treatment before their ulcers healed, and more did so in the hosiery group
(38%) than in the bandage group (28%; P ¼ .02). Adverse event frequency
was similar in both groups except that in the hosiery group there were more
non-serious adverse events (67% vs 58%) than in the bandage group. In
follow-up, 14% of the patients in the hosiery group had ulcer recurrence
compared with 23% of patients in the bandage group: hazard ratio, 0.56;
95% CI, 0.33-0.94; P ¼ .026. Mean average costs were £300 lower per
participant in the hosiery group than in the bandage group with the differ-
ence ascribed to more frequent nurse consultations in the bandage group.
Comment: The data indicate that the two forms of compression
tested are both quite effective in the healing of venous leg ulcers. The higher
rate of treatment changes in the participants of the hosiery group suggests
that hosiery may not be suitable for all patients with venous leg ulcers.
Treatment modality is likely best individualized based on potential patient
compliance and center expertise.
Compression Stockings to Prevent Post-Thrombotic Ayndrome: A
Randomised Placebo-Controlled Trial
Kahn SR, Shapiro S, Wells PS, et al. Lancet 2014;383:880-8.
Conclusions: Elastic compression stockings do not prevent post-
thrombotic syndrome (PTS) after a ﬁrst proximal deep venous thrombosis
(DVT).
Summary: Two previous single center randomized trials have sug-
gested that wearing elastic compression stockings for 2 years after proximal
DVT can halve the risk of developing PTS. The trials, however, were small
and not placebo controlled. It is obvious that stockings can be cumbersome
to apply, can be hot and uncomfortable, and can itch in many patients. In
addition, they can be expensive, up to $100 or more per pair, and need to
be replaced twice yearly because of wear and tear, and frequently are not
covered by health care plans. PTS reduces quality of life and poses a substan-
tial economic burden on patients and society. Therefore any technique to
prevent post-thrombotic syndrome in patients with DVTwould be welcome.
The authors conducted a multicenter randomized placebo-controlled trial of
active versus placebo elastic compression stockings used for 2 years in an
effort to prevent PTS after a ﬁrst proximal DVT. Patients with an ultrasound
conﬁrmed ﬁrst proximal DVTwere randomly assigned to study groups with a
web based randomization system. Any patient with a ﬁrst symptomatic prox-
imal DVT was eligible for the study. The patients were excluded if the use of
compression stockings was contraindicated or they had an expected life ex-
pectancy of less than 6 months or geographic inaccessibility that precluded
return for follow-up visits or if they were unable to apply stockings or they
had received thrombolytic therapy as part of their initial treatment of acute
DVT. The primary outcome was PTS diagnosed at 6 months or later using
Ginsberg’s criteria (leg pain and swelling of$1 month duration). Secondary
outcomes included cumulative incidence and severity of PTS with Villalta’s
score, objectively conﬁrmed recurrent venous thromboembolism, death,
adverse events, venous valvular reﬂux, and quality of life. The authors used
a modiﬁed intention to treat Cox regression analysis, supplemented by pre-
speciﬁed per-protocol analysis of patients who reported frequent use of their
allocated treatment. The active stockings were 30-40 mm Hg stockings
whereas the placebo stockings provided only 5 mm Hg of compression at
the level of the ankle. The stocking appeared similar and patients were asked
not to wear their stockings to their follow-up visits which occurred at 1, 6, 12,
18, and 24 months. From 2004 to 2010, 410 patients were randomly
assigned to receive active elastic compression stockings and 396 placebo
elastic compression stockings. The cumulative incidence of PTS was 14.2%
in the active ECS versus 12.7% in the placebos ECS group (hazard ratio
adjusted for center, 1.13; 95% CI, 0.73-1.76; P ¼ .58). Results were similar
in the prespeciﬁed per-protocol analysis of patients who reported frequent useof stockings. In addition the 2 year cumulative incidence of Villalta-deﬁned
PTS in both the active and placebo stocking groups in this study were similar
to the control arms of previous trials that had reported beneﬁt of stockings
(Brandjes DPM et al, Lancet 1997;349:759-62, and Prandoni P et al, Ann
Intern Med 2004;141:249-56).
Comment: Results of this trial do not support the routine use of
elastic compression stockings after proximal DVT to prevent PTS. Howev-
er, while the results suggest that elastic compression stockings might not
affect the natural history of PTS development after DVT, whether compres-
sion stockings might be of beneﬁt to improve symptoms of established PTS
or of acute DVT remain open questions.
Endovascular or Open Repair Strategy for Ruptured Abdominal Aortic
Aneurysm: Thirty-Day Outcomes from IMPROVE Randomised Trial
IMPROVE trial investigators, Powell JT, Sweeting MJ, et al. BMJ
2014;348:f7661.
Conclusions: In patients with ruptured abdominal aortic aneurysm
(rAAA) a strategy of endovascular repair is not associated with signiﬁcant
reduction in 30- day mortality or cost.
Summary: Endovascular repair for rAAA has emerged as a treatment
strategy for anatomically suitable patients with rAAA. This has been on the
basis of observational studies which have suggested that repair of rAAA
with EVAR may be associated with lower perioperative mortality than repair
of rAAA with open techniques. However, observational studies do not
consider individual center expertise and this potentially inﬂuences selection
of patients and diagnostic criteria. A recent trial from The Netherlands found
no difference in 30-day mortality between EVAR and open repair groups
withmortality rates of 21% and 25% respectively in theDutch trial (Reimerink
JJ et al, Ann Surg 2013; 258:248-56). However, in the Dutch trial only pa-
tients anatomically suitable for endovascular repair were randomized to either
endovascular or open repair. Investigators in the IMPROVE trial felt their
method of randomization was more of a real world scenario. In IMPROVE,
patients were randomized either to an endovascular strategy (immediate CT
scan followed by EVAR if locally determined as anatomically suitable for
EVAR and open repair when not suitable) or to immediate open repair
with CT being optional. IMPROVE enrolled patients from 29 vascular cen-
ters in the UK and one in Canada from 2009 to 2013. There were 613
eligible patients (480 men) with a clinical diagnosis of rAAA. Three hundred
sixteen patients were randomized to the endovascular strategy and the diag-
nosis of rAAA was conﬁrmed in 275 (87%), 8 (3%) had repair of a symptom-
atic nonruptured AAA in the same admission, and 33 (10%) had other
discharge diagnoses. Of the patients with ruptured or symptomatic AAA
272 had a CT performed and 174 (64%) were considered anatomically suit-
able for EVAR with local reporting of unfavorable anatomy at the aneurysm
neck the most common reason for lack of suitability for EVAR (75/84 cases).
EVAR was then attempted in 154 patients (four converted to open repair),
open repair was attempted in 112 other patients (84 anatomically unsuitable
for EVAR. There were 28 crossovers who were anatomically suitable for
EVAR, 16 patients died before aneurysm repair, and 1 patient with a symp-
tomatic aneurysm refused repair and was discharged). There were 297 pa-
tients randomized to open repair with the diagnosis of rAAA conﬁrmed in
261 (88%). Fourteen (5%) had repair of a symptomatic intact aneurysm in
the same admission and 22 (7%) had another discharge diagnosis. In this
group EVAR was attempted in 36 (13%) patients and open repair in 220
(80%) patients, and 19 patients died before aneurysm repair. Main outcome
measures were 30-day mortality and 24-hour and in-hospital mortality, costs,
with and time and place of discharge as secondary outcomes. 30-day mortal-
ity was 35.4% in the endovascular strategy group and 37.4% in the open repair
group: odds ratio, 0.92 (95% CI, 0.66-1.28, P¼ .62); odds ratio after adjust-
ment for age, sex, and Hardman index, 0.94 (95% CI, 0.67-1.33). Endovas-
cular strategy may have provided some beneﬁt for women (interaction test,
P ¼ .02), odds ratio, 0.44 (95% CI, 0.22-0.91) versus 1.18 (95% CI, 0.80-
1.75). Thirty-day mortality for patients with conﬁrmed rupture was 36.4%
(100/275) in the endovascular strategy group and 40.6% (106/261) in
the open repair group (P¼ .31). There were more patients in the endovascu-
lar strategy than in the open repair group who were discharged directly to
home (189/201 [94%] v 141/183 [77%]; P < .001). Average 30-day costs
were similar between the groups.
Comment: The study indicates that an endovascular strategy for a rAAA
has similar mortality as open surgical repair of rAAA. It also suggests, however,
that an endovascular strategy may beneﬁt women patients with rAAAA and
may result in a greater ability to discharge patients to home with less time in
the ICU than open surgery for a rAAA. Observational studies previously re-
ported improvedmortality results with endovascular repair for rAAAhave likely
been subject to institutional bias, selection bias and perhaps reporting bias.
Nevertheless, a strategy for repair of rAAA that includes possible endovascular
repair may offer beneﬁts for selected patients in terms of reduced time in the
ICU and a greater ability to discharge home.
